(Q46415775)

22 December 2017

title

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers (English)

1 reference

22 December 2017

author name string

Marcelino JJ

series ordinal

1

1 reference

22 December 2017

Feingold KR

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

22 December 2017

American Journal of Medicine

published in

1 reference

22 December 2017

volume

100

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

605-610

1 reference

22 December 2017

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

How often is medication taken as prescribed? A novel assessment technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900011-3

10.1016/S0002-9343(96)00011-3

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

8678079

1 reference

22 December 2017